BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4064984)

  • 1. Glottic carcinomas: a retrospective study of 101 cases.
    Broniatowski M
    Ear Nose Throat J; 1985 Nov; 64(11):527-31. PubMed ID: 4064984
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of radiation therapy in stage I and II glottic squamous cell carcinoma.
    Witt RL
    Del Med J; 1995 Aug; 67(8):430-5. PubMed ID: 7664954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis.
    Laccourreye O; Diaz EM; Bassot V; Muscatello L; Garcia D; Brasnu D
    Cancer; 1999 Jan; 85(1):40-6. PubMed ID: 9921972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival of glottic carcinoma patients treated with definitive radiation therapy: value of the Sixth edition of the UICC TNM staging system].
    Murakami R; Baba Y; Nishimura R; Morishita S; Tsuchigame T; Yamashita Y; Yumoto E
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Nov; 64(8):570-4. PubMed ID: 15651363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary subglottic cancer.
    Dahm JD; Sessions DG; Paniello RC; Harvey J
    Laryngoscope; 1998 May; 108(5):741-6. PubMed ID: 9591557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of cervical lymphatic metastasis to prognosis of glottic carcinoma: a report of 333 cases].
    Zhang Q; Lai FY; Guo ZM; Zeng ZY; Song M; Yu WB; Yang CS
    Ai Zheng; 2007 Oct; 26(10):1138-42. PubMed ID: 17927888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
    Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and pitfalls of stage I/II glottic cancer.
    Tateya I; Hirano S; Kitamura M; Kada S; Ishikawa S; Kanda T; Asato R; Tanaka S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):62-7. PubMed ID: 20879821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer of the larynx: the northern Alberta experience.
    Marck PA; Lupin AJ
    J Otolaryngol; 1989 Dec; 18(7):344-9. PubMed ID: 2593218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node status cannot be ignored in survival analysis of laryngeal cancer.
    Chatni SS; Thankappan K
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):786; author reply 786-7. PubMed ID: 18645134
    [No Abstract]   [Full Text] [Related]  

  • 15. [The prognostic value of conventional pathological anatomy in laryngeal epidermoid carcinoma].
    Fernández-Nogueras Jiménez FJ; Esquivias López-Cuervo J
    Acta Otorrinolaringol Esp; 1991; 42(3):169-76. PubMed ID: 1867907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative pathology following endoscopic resection of T1a squamous carcinoma of the glottis.
    Nassif R; Loughran S; Moyes C; MacKenzie K
    J Laryngol Otol; 2005 Aug; 119(8):592-4. PubMed ID: 16102211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Larynx squamous cell carcinoma: concepts and future directions.
    Mojica-Manosa P; Reidy J; Wilson K; Douglas W
    Surg Oncol Clin N Am; 2004 Jan; 13(1):99-112. PubMed ID: 15062364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten years single institutional experience of treatment for advanced laryngeal cancer in Kyoto University.
    Kada S; Hirano S; Tateya I; Kitamura M; Ishikawa S; Kanda T; Asato R; Tanaka S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):68-73. PubMed ID: 20879822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, risk factors, and overall survival rate of laryngeal cancer in Songklanagarind Hospital.
    Dechaphunkul T
    J Med Assoc Thai; 2011 Mar; 94(3):355-60. PubMed ID: 21560844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.